Once-daily dasatinib: expansion of phase II study evaluating safety and efficacy of dasatinib in patients with metastatic castration-resistant prostate cancer (Q36087899)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Once-daily dasatinib: expansion of phase II study evaluating safety and efficacy of dasatinib in patients with metastatic castration-resistant prostate cancer |
scientific article |
Statements
1 reference
Once-daily dasatinib: expansion of phase II study evaluating safety and efficacy of dasatinib in patients with metastatic castration-resistant prostate cancer (English)
1 reference
George Wilding
1 reference
Karim Fizazi
1 reference
Cora N Sternberg
1 reference
Evan Y Yu
1 reference
Christophe Massard
1 reference
Michael A Carducci
1 reference
Stephane Culine
1 reference
Gary Hudes
1 reference
Edwin M Posadas
1 reference
Géralyn C Trudel
1 reference
Prashni Paliwal
1 reference
1 May 2011
1 reference
1 reference
1166-1171
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference